VSee Health, Inc. (VSEE)
NASDAQ: VSEE · Real-Time Price · USD
0.5489
-0.0311 (-5.36%)
At close: Dec 5, 2025, 4:00 PM EST
0.5499
+0.0010 (0.18%)
After-hours: Dec 5, 2025, 7:55 PM EST
Company Description
VSee Health, Inc. provides telehealth care solutions in the United States.
The company offers iDoc Telehealth solutions that treat and coordinate care for acutely ill patients in the neurointensive care, cardiac intensive care, and intensive care units for stroke, spinal cord, brain trauma, and other neurological conditions.
It also provides telehealth software building blocks, such as patient engagement, clinician staffing, remote physical exam and remote patient monitoring, and AI for telesitter and telenursing solutions; data connectors; and workflow templates.
The company distributes its products through third-party resellers and affiliated hospitals, as well as sales executives.
VSee Health, Inc. is headquartered in Newton, Massachusetts.
VSee Health, Inc.
| Country | United States |
| Founded | 2008 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 154 |
| CEO | M.D. Dr. Imoigele P. Aisiku M.B.A. |
Contact Details
Address: One Gateway Center, Suite 507 Newton, Massachusetts 02458 United States | |
| Website | vseehealth.com |
Stock Details
| Ticker Symbol | VSEE |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001864531 |
| ISIN Number | US92919Y1029 |
| Employer ID | 86-2970927 |
| SIC Code | 8000 |
Key Executives
| Name | Position |
|---|---|
| Dr. Milton Chen Ph.D. | Co-Chief Executive Officer and Director |
| Dr. Imoigele P. Aisiku M.B.A., M.D. | Chairman of the Board and Co-Chief Executive Officer |
| Jerry Leonard CPA, M.B.A. | Chief Financial Officer |
| Erika Chuang Ph.D. | Chief of Products |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 4, 2025 | SCHEDULE 13D/A | Filing |
| Nov 28, 2025 | 8-K | Current Report |
| Nov 26, 2025 | 8-K | Current Report |
| Nov 24, 2025 | DEF 14A | Other definitive proxy statements |
| Nov 20, 2025 | 10-Q/A | [Amend] Quarterly report |
| Nov 17, 2025 | 8-K | Current Report |
| Nov 17, 2025 | 8-K | Current Report |
| Nov 14, 2025 | PRE 14A | Other preliminary proxy statements |
| Nov 14, 2025 | 10-Q | Quarterly Report |
| Nov 5, 2025 | SCHEDULE 13G | Filing |